Double-in vitro maturation increases the number of vitrified oocytes available for fertility preservation when ovarian stimulation is unfeasible

Archive ouverte

Sermondade, Nathalie | Grynberg, Michaël | Comtet, Marjorie | Valdelievre, Constance | Sifer, Christophe | Sonigo, Charlotte

Edité par CCSD ; Nature Publishing Group -

International audience. When ovarian stimulation is unfeasible, in vitro maturation (IVM) represents an alternative option for fertility preservation (FP). This retrospective study aims to evaluate the feasibility of performing within a short time frame two IVM cycles for FP. Seventeen women with breast cancer, 18-40 years of age, having undergone 2 cycles of IVM followed by oocyte vitrification were included. Non parametric analyses were used. No difference was observed between IVM1 and IVM2 outcomes. No complication was reported. The respective contributions of IVM1 and IVM2 for the number of cryopreserved oocytes were comparable irrespective of the delay between both procedures, even when performed during the same menstrual cycle. Those findings suggest that repeating IVM cycles may constitute a safe option for increasing the number of vitrified mature oocytes for FP. These two retrievals may be performed during the same cycle, providing additional argument for a physiologic continuous recruitment during follicular development.

Suggestions

Du même auteur

Influence of breast cancer prognostic factors on oocyte in vitro maturation outcomes performed for urgent fertility preservation

Archive ouverte | Raad, Jade | CCSD

International audience. Abstract STUDY QUESTION Do breast cancer (BC) characteristics influence IVM of oocytes outcomes in patients undergoing fertility preservation (FP)? SUMMARY ANSWER Scarff-Bloom-Richardson (SBR...

Serum antimüllerian hormone is associated with the number of oocytes matured in vitro and with primordial follicle density in candidates for fertility preservation

Archive ouverte | Sermondade, Nathalie | CCSD

International audience

BRCA1/2 gene mutations do not affect the capacity of oocytes from breast cancer candidates for fertility preservation to mature in vitro

Archive ouverte | Grynberg, Michaël | CCSD

International audience. Are the maturation rates of oocytes recovered from small antral follicles different between breast cancer patients presenting with or without a BRCA 1/2 gene mutation? . ...

Chargement des enrichissements...